Fate Therapeutics Stock Buy Or Sell
Skip chart chart data in insider trading history table. 12278 scripps summit drive , san diego, ca 92131.
Monday, december 14, 2020 03:32 pm | investorsobserver analysts fate therapeutics inc ( fate ) stock is higher by 373.19% over the last 12 months, and the average rating from wall street analysts is a strong buy.
Fate therapeutics stock buy or sell. Out of them, 4 rate it a hold, while 15 recommend buy, whereas 0 assign an overweight rating. What is the fate therapeutics inc stock quote today? Fate) is owned by 99.29% institutional shareholders, 60.70% fate therapeutics insiders, and 0.00% retail investors.
You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. Is fate stock a buy? Analysts have rated the stock buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
During the day the stock fluctuated 10.17% from a day low at $52.09 to a day high of $57.38. How to buy fate therapeutics inc stock online? (fate) as underweight, while 0 advise sell.
Fate therapeutics stocks (fate.us) are listed on the nasdaq and all prices are listed in us dollars. Overall, hedge fund sentiment was unchanged. 18.58% of the stock of fate therapeutics is held by insiders.
In the past three months, fate therapeutics insiders have sold more of their company's stock than they have bought. Nasdaqgm:fate insider trading volume august 22nd 2021 Yes, fate therapeutics inc is a publicly traded company.
Declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.” Specifically, they have bought $0.00 in company stock and sold $7,050,334.00 in company stock. (nasdaq:fate) ceo j scott wolchko sold 20,000 shares of fate therapeutics stock in a transaction that occurred on thursday, november 18th.
Use the zacks rank and style scores to find out is fate is right for your portfolio. After each calculation the program assigns a buy, sell, or hold. 0 analyst(s) have tagged fate therapeutics inc.
In the last year fate therapeutics insiders didn't buy any company stock. Out of 9 analysts, 5 ( 55.56% ) are recommending fate as a strong buy, 2 ( 22.22% ) are recommending fate as a buy, 2 ( 22.22% ) are recommending fate as a hold, 0 ( 0% ) are recommending fate as a sell, and 0 ( 0% ) are recommending fate as a strong sell. Opinions of the stock are interesting as 13 analysts out of 18 who provided ratings for fate therapeutics inc.
Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. The shares were sold at an average price of $54.27, for a total value of $1,085,400.00. Real time fate therapeutics (fate) stock price quote, stock graph, news & analysis.
The transaction was disclosed in a filing with the sec, which can be accessed through this hyperlink. Overall, hedge fund sentiment was unchanged. Find the latest fate therapeutics, inc.
Fate therapeutics inc (nasdaq:fate) shares haven't seen a lot of action during the second quarter. If you're an aggressive investor and you are only putting [in] a small portion of your overall portfolio, fate therapeutics might be a stock. Is fate therapeutics inc stock public?
Do not sell my personal information (fate) stock quote, history, news and other vital information to help you with your stock trading and investing. Fate) stock is to strong buy fate stock.
Fate therapeutics inc (fate) stock: 3 of the most innovative stocks to buy now. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Should i buy fate therapeutics (fate)? Fate therapeutics inc (nasdaq:fate) shares haven’t seen a lot of action during the second quarter. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.
Group llc redmile's fate therapeutics shares are currently valued at $1. Fate therapeutics is a biotechnology business based in the us. Fate therapeutics insider trading history chart.
The fate therapeutics inc stock price is 48.00 usd today. This chart shows the insider buying and selling history at fate therapeutics by year and by quarter. Group llc redmile is the largest individual fate therapeutics shareholder, owning 25.92m shares representing 27.14% of the company.
Is fate stock a buy? 9 wall street analysts covering (nasdaq:
Post a Comment for "Fate Therapeutics Stock Buy Or Sell"